Heat shock protein gp96 vaccination and methods of using same

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/16 (2006.01) A61K 35/12 (2006.01) A61K 39/395 (2006.01) A61K 48/00 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2718884

The invention provides a tumor cell genetically modified to express a nucleic acid encoding a secreted form of a heat shock protein (hsp) gp96 polypeptide. The invention also provides a method of stimulating an immune response to a tumor by administering a tumor cell genetically modified to express a nucleic acid encoding a secreted form of a gp96 polypeptide.

Cette invention concerne une cellule tumorale génétiquement modifiée pour exprimer un acide nucléique codant pour une forme sécrétée d'un polypeptide de la protéine de choc thermique (hsp) gp96. L'invention concerne également un procédé de stimulation d'une réponse immunitaire à une tumeur par administration d'une cellule tumorale génétiquement modifiée pour exprimer un acide nucléique codant pour une forme sécrétée d'un polypeptide de gp96.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Heat shock protein gp96 vaccination and methods of using same does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heat shock protein gp96 vaccination and methods of using same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heat shock protein gp96 vaccination and methods of using same will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1348189

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.